Two new sulfur-containing phenolic compounds, 7-hydroxy-5-hydroxymethyl-2H-benzo[1,4]thiazin-3-one (1) and 2,5-dihydroxy-3-methanesulfinylbenzyl alcohol (2), along with two known compounds, 3-chloro-2,5-dihydroxybenzyl alcohol (3) and 2-hydroxy-6-methylbenzoic acid (4), were isolated from the mycelial solid culture of a soil-derived Ampelomyces fungus by antibacterial assay-guided fractionation. Their structures were elucidated on the basis of spectroscopic analysis. Compounds 1-3 showed structure and microbial dependent antibacterial activities.
Natural products play a dominant role in the discovery of lead compounds for the development of drugs for the treatment of human diseases. 1) Microorganisms are prolific producers of natural products many of which have been used as antibiotics, anticancer drugs, immunosuppressant agents, and other types of medications. Among these, filamentous fungi are historically an important source of bioactive secondary metabolites, and they continue to provide new chemical entities with novel biological activities. 2) In search of new antibacterial and antifungal metabolites produced by microorganisms isolated in South China, 3, 4) an EtOH extract from a mycelial solid culture of a soil-derived fungus, Ampelomyces sp. SC0307, was found to show antibacterial activity against Staphylococcus aureus and Escherichia coli. The active metabolites of this fungus were therefore investigated. Two new sulfur-containing phenolic compounds (1 and 2) and two known phenolics (3 and 4) were isolated from the mycelial cultures by antibacterial assay-guided fractionation. Here we report the isolation, structure elucidation, and antibacterial activities of these compounds. 
O

Experimental
General. Optical rotation was obtained on a PerkinElmer 343 spectropolarimeter (Perkin-Elmer, Boston, MA). UV spectra were recorded in MeOH on a PerkinElmer Lambda 25 UV-vis spectrophotometer. IR spectra were measured in KBr on a WQF-410 FT-IR spectrophotometer (Suntek Science Instrument, Tianjin).
1 H-NMR (400 MHz), 13 C-NMR (100 MHz), and 2D NMR spectra were recorded on a Bruker DRX-400 instrument (Bruker BioSpin, Ettlingen) using TMS as an internal reference. HRESIMS data were obtained on an API QSTAR TOF mass spectrophotometer (AB MDS Sciex, Toronto) in negative-ion mode. ESIMS were collected on MDS SCIEX API 2000 LC/MS/MS instrument (AB MDS Sciex, Toronto). For column chromatography, silica gel 60 (100-200 mesh, Qingdao Marine Chemical, Qingdao), Develosil ODS (10 mm, Nomura Chemical, Seto), and Sephadex LH-20 (Pharmacia Fine Chemicals, Uppsala) were used. TLC was performed on precoated silica gel plates (GF 254 , Qingdao Marine Chemical) with detection under fluorescent light ( ¼ 254 nm), exposure in I 2 vapor, and spraying with H 2 SO 4 (10%) in EtOH, followed by heating. Fermentation. Mycelia of Ampelomyces sp. SC0307 grown on PDA (potato-dextrose agar) plates were used to inoculate 30 100-ml Erlenmeyer flasks containing 20 ml of YMG (yeast-malt-glucose) medium. The flasks were incubated on a rotary shaker for 3 d in the dark at 28 C with shaking at 120 rpm. Then the cultures were transferred into 30 500-ml Erlenmeyer flasks containing 100 ml of YMG medium. These 500-ml flasks were incubated under the same conditions. Three d later, the cultures were transferred into 30 5,000-ml Erlenmeyer flasks containing 1,000 ml of YMG medium and 550 g of wheat grains, and cultivation was carried out in the stationary phase in the dark at 28 C for 7 d.
Extraction and isolation. Mycelial solid cultures were extracted with 95% EtOH 3 times at room temperature. The resulting EtOH solution, after concentration in vacuo, was suspended in H 2 O, and this aqueous suspension was sequentially extracted 3 times each with petroleum ether, CHCl 3 , EtOAc, and n-BuOH. The resulting extracts were subjected to antibacterial assay. The EtOAc-soluble extract (36 g) showing the most potent activity was subjected to passage over a silica gel column and eluted with CHCl 3 -MeOH mixtures of increasing polarity (100:0 to 60:40) to obtain 10 fractions (I-X). These fractions were then tested in antibacterial assay. The active fractions, II, VIII, and IX, were chosen for further fractionation. Fraction II, obtained by elution of CHCl 3 -MeOH (98:2), was separated by silica gel column chromatography eluted with CHCl 3 -MeOH (95:5) to afford 4 (10 mg). Fraction VIII, obtained by elution of CHCl 3 -MeOH (9:1), was chromatographed over a Sephadex LH-20 column, eluted with MeOH, and then purified by HPLC (Shimazu LC-6A pump, Shimazu RID-10A refractive index detector, XTerra prep MS C 18 column, 10 mm, 300 Â 19 mm, elution with 60% MeOH), to afford 3 (430 mg). Fraction IX, obtained on elution with CHCl 3 -MeOH (9:1), was subjected to column chromatography over silica gel with petroleum ether-acetone (55:45), followed by purification on a Sephadex LH-20 column eluted with MeOH, to afford 1 (14 mg) and 2 (18 mg).
7-Hydroxy-5-hydroxymethyl-2H-benzo [1, 4] thiazin-3-one (1). White powder; UV(MeOH) max (log "): 220 (3.70), 243 (3.70), 293 (3.16) nm; positive ESIMS: m=z Antibacterial activity. The activity was tested against four bacterial strains, including a Gram positive strain (S. aureus ATCC6538) and Gram negative strains (E. coli, ATCC8739; Proteus vulgaris, CMCC49027; and Pseudomonas aeruginosa, ATCC9027), all obtained from the Microbial Culture Collection Center, Guangdong Institute of Microbiology, Guangzhou, China. The test bacteria were incubated on nutrient agar (NA) or nutrient broth (NB) at 32 C for 24 h prior to assay. Mueller-Hinton broth (MHB) and NA were used in the antibacterial assay.
The antibacterial activity of the pure compounds was evaluated by microplate Alamar Blue assay (MABA), 5) with minor modifications. Serial 2-fold dilutions of compounds 1-4 and Ceftazidime (positive control) were made in DMSO, and the test bacteria at a concentration of 2 Â 10 5 CFU/ml were prepared in MHB medium supplemented with 8% (v/v) Alamar Blue. In a 96-well plate, 78 ml of each test organism and 2 ml each of the compound dilutions were mixed and incubated at 32 C until growth control wells developed the growth (pink color). The fluorescence intensity was then measured using a plate reader (Synergy HT, Bio-Tek, Winooski, VT) with excitation at 530 nm and emission at 590 nm. The percentage inhibition of each compound dilution was calculated. All tests were run in triplicate and averaged. IC 50 values, 6) defined as the concentration required to reduce bacterial growth by 50%, was obtained by interpolation of concentration-inhibition curves.
During bioassay-guided fractionation, the antibacterial activity of the extracts and fractions against S. aureus and E. coli was monitored by the agar diffusion method with paper disks.
3) The test dosage was 100 mg per paper disk for all extracts and fractions. Activity was assessed by the sizes of inhibition zones.
Results and Discussion
Bioassay-guided fractionation of the aforementioned EtOAc-soluble fraction by silica gel and Sephadex LH-20 column chromatography furnished two new compounds, 1 and 2, together with known compounds, 3-chloro-2,5-dihydroxybenzyl alcohol (3) 7,8) and 2-hydroxy-6-methylbenzoic acid (4).
9) The structures of compounds 3 and 4 were identified by interpretation of their spectral data (ESIMS, 1 H-NMR, 13 C-NMR, and UV) as well as by a comparison of the data with those reported in the relevant literature.
Compound 1 was obtained as a white powder. Its molecular formula, C 9 H 9 NO 3 S, was established by analysis of its 1 H-and 13 C-NMR spectra as well as negative HRESIMS, which gave a pseudo-molecular ion ½M À H À at m=z 210.0226. The 13 C NMR spectrum showed the presence of nine carbons, of which six were aromatic carbons, including two methine carbons and four quaternary carbons, of which one was oxygenated [ 153.5 (C-7)], one was an amide carbonyl carbon [ 164.8 (C-3)], and two were methylene carbons with one oxygenated [ 63.5 (C-11)]. The 1 H NMR spectrum exhibited two doublets at 6.75 (1H, d, J ¼ 2:2 Hz, H-8) and 6.67 (1H, d, J ¼ 2:2 Hz, H-6), characteristic of a 1,2,3,5-tetrasubstituted benzene ring, two singlets at 4.69 (2H, s, H 2 -11) and 3.38 (2H, s, H 2 -2), indicating the presence of two isolate methylenes, and three broad signals at 8.99, 8.45, and 4.84 (1H each) attributable to three exchangeable protons. In the HMBC spectrum of 1 (key correlations depicted in Fig. 1 ), correlations were observed from H-6, H-8, and H 2 -11 to the aromatic quaternary carbon at 130.0 (C-10); from H 2 -2 to C-3 and the aromatic quaternary carbon at 122.5 (C-9); and from both H-8 and H-6 to C-7. These findings indicate that 1 was an analog of a known structure of 7-hydroxy-2H-benzo [1, 4] thiazin-3-one 10, 11) with a hydroxymethyl group attached at the C-5 position. Thus the structure of 1 was deduced as depicted.
Compound 2 was isolated as a white powder. The molecular formula, C 8 H 10 O 4 S, was deduced from the HRESIMS ion at m=z 201.0222 ½M À H À in combination with 13 C-NMR and ESIMS data. The IR spectrum exhibited a strong absorption band at 1,000 cm À1 , suggesting the presence of a sulfoxide group (S=O). . The long-range correlations from H 2 -7 to C-2 and C-6, from OH-5 to both C-4 and C-6, and from OH-2 and SOCH 3 to C-3 observed in the HMBC spectrum (Fig. 1 ) indicated the attachment of the hydroxymethyl group to C-1, the methanesulfinyl group to C-3, and two phenolic hydroxyl groups to C-2 and C-5 respectively. Therefore, compound 2 was identified as 2,5-dihydroxy-3-methanesulfinylbenzyl alcohol. This compound, with a chiral center at the sulfur atom of the sulfinyl group, was found to exist as a racemic mixture because it was optically inactive.
It is noteworthy that compound 3 has been isolated from a marine-derived fungus, Ampelomyces sp. UST040128, as a potent antifouling and antimicrobial agent. 8) Our current investigation resulted in the isolation of the same compound from a terrestrial fungus, Ampelomyces sp. SC0307, which, besides providing an alternative source of the bioactive compound 3, might shed some light on the evolution of fungi.
For a better understanding of their structure and activity relationships (SARs), these structurally related compounds were evaluated for antibacterial activities against a Gram positive strain (S. aureus) and Gram negative bacteria (E. coli, P. vulgaris, and P. aeruginosa) by microplate Alamar Blue assay (MABA). As shown in Table 1 , compounds 1-3, all possessing a structure of 2-substituted 5-hydroxybenzyl alcohol with a C-3 bearing heteroatom, exhibited activity against certain test bacteria. Compound 1 showed the most potent growth inhibition against P. aeruginosa, comparable with that of the positive control substance Ceftazidime, a commercial medication for the treatment of infections caused by Pseudomonas aeruginosa, and moderate activity towards S. aureus as well E. coli but no activity towards P. vulgaris. Compound 2 inhibited the growth of all the tested Gram negative bacteria, with IC 50 values ranging from 13.62 to 65.59 mg/ml, but no activity to S. aureus. Compound 3 exhibited unselectively good growth inhibitory activity towards bacteria, E. coli, P. vulgaris, and particularly S. aureus, with a slightly higher potency (IC 50 ¼ 1:56 mg/ml) than Ceftazidime, but no activity against P. aeruginosa. However, compound 4 showed no growth inhibition towards any of the tested Gram positive or negative bacteria. A detailed analysis of the activity profiles of these compounds suggested that despite their high similarity, they exhibited different activity spectra against the bacteria tested in our experiment, which suggests that the growth inhibition of these compounds is highly structure-and microbial-dependent. Therefore, these compounds might represent a simple template of natural anti-bacterial agents, and their unique activity merits further investigation, which might lead to the discovery of new therapeutic agents. Values are the means of three experiments AE standard deviation (SD).
